abstract |
The present invention provides compounds that are selective allosteric inhibitors of TMLR, TMLRCS, LR, LRCS comprising EGFR mutants, their preparation, pharmaceutical compositions comprising the compounds and the use of the compounds as therapeutically active substances. |